CA2988481C - Polypeptides et polynucleotides d'adenovirus - Google Patents

Polypeptides et polynucleotides d'adenovirus

Info

Publication number
CA2988481C
CA2988481C CA2988481A CA2988481A CA2988481C CA 2988481 C CA2988481 C CA 2988481C CA 2988481 A CA2988481 A CA 2988481A CA 2988481 A CA2988481 A CA 2988481A CA 2988481 C CA2988481 C CA 2988481C
Authority
CA
Canada
Prior art keywords
adenoviral
suitably
protein
seq
polynucleotide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2988481A
Other languages
English (en)
Other versions
CA2988481A1 (fr
Inventor
Virginia Ammendola
Stefano Colloca
Riccardo Cortese
Fabiana GRAZIOLI
Alfredo Nicosia
Alessandra Vitelli
Original Assignee
GlaxoSmithKline Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1510357.5A external-priority patent/GB201510357D0/en
Priority claimed from PCT/EP2015/063248 external-priority patent/WO2015189425A1/fr
Priority claimed from GBGB1514772.1A external-priority patent/GB201514772D0/en
Application filed by GlaxoSmithKline Biologicals SA filed Critical GlaxoSmithKline Biologicals SA
Priority claimed from PCT/EP2016/063329 external-priority patent/WO2016198621A1/fr
Publication of CA2988481A1 publication Critical patent/CA2988481A1/fr
Application granted granted Critical
Publication of CA2988481C publication Critical patent/CA2988481C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

L'invention concerne, entre autres, un polynucléotide isolé, le polynucléotide codant un polypeptide choisi dans le groupe constitué par : (a) un polypeptide ayant la séquence d'acides aminés selon SEQ ID NO: 1, (b) un dérivé fonctionnel d'un polypeptide ayant la séquence d'acides aminés selon SEQ ID NO: 1, le dérivé fonctionnel ayant une séquence d'acides aminés qui est au moins 80 % identique, sur toute sa longueur, à la séquence d'acides aminés de SEQ ID NO: 1, et (c) un polypeptide ayant la séquence d'acides aminés selon SEQ ID NO: 3.
CA2988481A 2015-06-12 2016-06-10 Polypeptides et polynucleotides d'adenovirus Active CA2988481C (fr)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GBGB1510357.5A GB201510357D0 (en) 2015-06-12 2015-06-12 Adenovirus polynucleotides and polypeptides
EPPCT/EP2015/063248 2015-06-12
PCT/EP2015/063248 WO2015189425A1 (fr) 2014-06-13 2015-06-12 Combinaisons immunogènes
GB1510357.5 2015-06-12
GBGB1514772.1A GB201514772D0 (en) 2015-08-19 2015-08-19 Adenovirus polynucleotides and polypeptides
GB1514772.1 2015-08-19
PCT/EP2016/063329 WO2016198621A1 (fr) 2015-06-12 2016-06-10 Polypeptides et polynucléotides d'adénovirus

Publications (2)

Publication Number Publication Date
CA2988481A1 CA2988481A1 (fr) 2016-12-15
CA2988481C true CA2988481C (fr) 2025-11-18

Family

ID=

Similar Documents

Publication Publication Date Title
AU2019202081B2 (en) Adenovirus polynucleotides and polypeptides
US11795478B2 (en) Adenovirus polynucleotides and polypeptides
US20230158134A1 (en) Chimpanzee adenovirus constructs with lyssavirus antigens
US11702674B2 (en) Simian adenovirus vectors comprising the ChAd-157 fiber protein
CA2988481C (fr) Polypeptides et polynucleotides d'adenovirus
EA042571B1 (ru) Полинуклеотиды и полипептиды аденовируса
EA039001B1 (ru) Аденовирусные полинуклеотиды и полипептиды